Table 1 Baseline characteristics of participants according to sarcopenia status.
From: A sarcopenia screening test predicts mortality in hospitalized older adults
Characteristic | No sarcopenia (n = 116) | Sarcopenia (n = 264) | p |
|---|---|---|---|
Age (years) | 79.7 ± 7.2 | 81.3 ± 6.9 | 0.535 |
Women | 35 (30.2) | 65 (24.6) | 0.258 |
Current smokers | 17 (14.7) | 32 (12.1) | 0.497 |
Current alcohol drinkers | 19 (16.4) | 27 (10.2) | 0.090 |
Comorbidities | |||
Hypertension | 70 (60.3) | 155 (58.7) | 0.766 |
Ischemic heart disease | 44 (37.9) | 79 (29.9) | 0.124 |
COPD | 25 (21.6) | 94 (35.6) | 0.007 |
Diabetes | 35 (30.5) | 69 (26.1) | 0.416 |
Stroke | 2 (1.7) | 23 (8.7) | 0.011 |
CKD | 15 (12.9) | 38 (14.4) | 0.705 |
Acute infection | 40 (34.5) | 75 (28.4) | 0.235 |
Osteoarthritis | 25 (21.6) | 78 (29.5) | 0.106 |
Tumor of any type | 8 (6.9) | 34 (12.9) | 0.087 |
GI disease | 20 (17.2) | 53 (20.1) | 0.518 |
Liver disease | 12 (10.3) | 19 (7.2) | 0.302 |
Falls in the previous year | 9 (7.8) | 37 (14.0) | 0.085 |
Urinary incontinence | 12 (10.3) | 36 (13.6) | 0.374 |
Chronic pain | 35 (30.2) | 84 (31.8) | 0.750 |
Malnutrition | 8 (6.9) | 32 (12.1) | <0.001 |
Polypharmacy* | 35 (43.2) | 93 (48.4) | 0.429 |
Cognitive impairment* | 17 (21.0) | 79 (41.1) | 0.001 |
Depression* | 18 (22.2) | 50 (26.0) | 0.505 |
BMI (kg/m2) | |||
Women | 23.9 ± 3.6 | 22.1 ± 4.4 | 0.048 |
Men | 23.7 ± 3.6 | 21.7 ± 3.6 | <0.001 |
CC (cm) | |||
Women | 34.4 ± 3.4 | 30.1 ± 4.0 | <0.001 |
Men | 35.5 ± 2.8 | 31.6 ± 3.5 | <0.001 |
Gait speed (m/s) | |||
Women | 0.8 ± 0.3 | 0.7 ± 0.2 | 0.027 |
Men | 0.9 ± 0.5 | 0.7 ± 0.3 | 0.002 |
Handgrip strength (kg) | |||
Women | 21.0 ± 3.8 | 10.2 ± 5.2 | <0.001 |
Men | 30.4 ± 6.4 | 18.8 ± 6.9 | <0.001 |
Hemoglobin (g/L) | 125.1 ± 21.1 | 121.3 ± 22.8 | 0.126 |
Prealbumin (mg/L) | 202.0 ± 53.1 | 192.2 ± 65.7 | 0.291 |
1-year mortality | 9 (8.3) | 28 (11.5) | 0.362 |
2-year mortality | 10 (9.2) | 43 (17.6) | 0.040 |
3-year mortality | 14 (12.8) | 53 (21.7) | 0.049 |
